Skip to main content
. 2023 Apr 18;23:70. doi: 10.1186/s12911-023-02168-6

Table 5.

Descriptive statistics of the study population – Experiment 3

Overall study sample Mortality
Total 445 32 (7.2%)
Age Group  < 70 307 (69.0%) 7 (2.3%)
 ≥ 70 138 (31.0%) 25 (18.1%)
Sex Female 107 (24.0%) 10 (9.3%)
Male 338 (76.0%) 22 (6.5%)
BMI Excess (≥ 25) 278 (62.5%) 18 (6.5%)
Not excess (< 25) 123 (27.6%) 8 (6.5%)
NA 44 (9.9%) 6 (13.6%)
Symptoms Asymptomatic 4 (0.9%) 0 (0.0%)
Tiredness 1 (0.2%) 0 (0.0%)
Dyspnea 5 (1.1%) 2 (40.0%)
Chest pain 409 (91.9%) 26 (6.4%)
Cardiac arrest/Sudden death aborted 6 (1.3%) 0 (0.0%)
Syncope 6 (1.3%) 0 (0.0%)
Dizziness 8 (1.8%) 3 (37.5%)
NA 6 (1.3%) 1 (16.7%)
ACS Time  < 6 h 285 (64.0%) 17 (6.0%)
6 h to 12 h 81 (18.2%) 7 (8.6%)
12 h to 24 h 39 (8.8%) 3 (7.7%)
 < 7 days 25 (5.6%) 3 (12.0%)
 < 15 days 3 (0.7%) 0 (0.0%)
Unknown 1 (0.2%) 0 (0.0%)
NA 11 (2.5%) 2 (18.2%)
Heart Rate AVB 2nd degree, Mobitz I 2 (0.4%) 1 (50.0%)
AVB 2nd degree, Mobitz II 1 (0.2%) 0 (0.0%)
AVB 3rd degree 3 (0.7%) 2 (66.7%)
Atrial fibrillation 18 (4.0%) 4 (22.2%)
Pacing 6 (1.3%) 0 (0.0%)
Junctional rhythm 1 (0.2%) 1 (100.0%)
Sinus rhythm 389 (87.4%) 24 (6.2%)
NA 25 (5.6%) 0 (0.0%)
N. º of Segments with Injury 1 126 (28.3%) 5 (4.0%)
2 107 (24.0%) 6 (5.6%)
3 79 (17.8%) 4 (5.1%)
4 51 (11.5%) 4 (7.8%)
5 33 (7.4%) 3 (9.1%)
6 24 (5.4%) 6 (25.0%)
7 15 (3.4%) 2 (13.3%)
8 5 (1.1%) 2 (40.0%)
9 1 (0.2%) 0 (0.0%)
10 4 (0.9%) 0 (0.0%)